EAM Investors’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-66,030
| Closed | -$2.36M | – | 362 |
|
|
2022
Q4 | $2.36M | Buy |
66,030
+31,004
| +89% | +$1.11M | 0.49% | 66 |
|
|
2022
Q3 | $1.19M | Buy |
+35,026
| New | +$1.19M | 0.26% | 172 |
|
|
2018
Q3 | – | Sell |
-53,910
| Closed | -$3.23M | – | 365 |
|
|
2018
Q2 | $3.23M | Buy |
+53,910
| New | +$3.23M | 0.51% | 73 |
|
|
2017
Q4 | – | Sell |
-58,967
| Closed | -$2.36M | – | 343 |
|
|
2017
Q3 | $2.36M | Sell |
58,967
-17,725
| -23% | -$709K | 0.31% | 143 |
|
|
2017
Q2 | $3.31M | Buy |
+76,692
| New | +$3.31M | 0.55% | 55 |
|
|
2016
Q4 | – | Sell |
-143,679
| Closed | -$3.55M | – | 362 |
|
|
2016
Q3 | $3.55M | Sell |
143,679
-44,598
| -24% | -$1.1M | 0.48% | 49 |
|
|
2016
Q2 | $3.84M | Buy |
+188,277
| New | +$3.84M | 0.58% | 22 |
|
|
2016
Q1 | – | Sell |
-236,833
| Closed | -$3.18M | – | 341 |
|
|
2015
Q4 | $3.18M | Buy |
236,833
+21,568
| +10% | +$290K | 0.42% | 96 |
|
|
2015
Q3 | $3.02M | Sell |
215,265
-58,252
| -21% | -$817K | 0.48% | 59 |
|
|
2015
Q2 | $4.64M | Buy |
+273,517
| New | +$4.64M | 0.54% | 39 |
|